<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="Statistical Issues in Testing Conformance with the Quantitative Imaging Biomarker Alliance (QIBA) Profile Claims" /><meta property="og:locale" content="en" /><meta name="description" content="A major initiative of the Quantitative Imaging Biomarker Alliance is to develop standards-based documents called “Profiles,” which describe one or more technical performance claims for a given imaging modality. The term “actor” denotes any entity (device, software, or person) whose performance must meet certain specifications for the claim to be met. The objective of this paper is to present the statistical issues in testing actors’ conformance with the specifications. In particular, we present the general rationale and interpretation of the claims, the minimum requirements for testing whether an actor achieves the performance requirements, the study designs used for testing conformity, and the statistical analysis plan. We use three examples to illustrate the process: apparent diffusion coefficient in solid tumors measured by MRI, change in Perc 15 as a biomarker for the progression of emphysema, and percent change in solid tumor volume by computed tomography as a biomarker for lung cancer progression." /><meta property="og:description" content="A major initiative of the Quantitative Imaging Biomarker Alliance is to develop standards-based documents called “Profiles,” which describe one or more technical performance claims for a given imaging modality. The term “actor” denotes any entity (device, software, or person) whose performance must meet certain specifications for the claim to be met. The objective of this paper is to present the statistical issues in testing actors’ conformance with the specifications. In particular, we present the general rationale and interpretation of the claims, the minimum requirements for testing whether an actor achieves the performance requirements, the study designs used for testing conformity, and the statistical analysis plan. We use three examples to illustrate the process: apparent diffusion coefficient in solid tumors measured by MRI, change in Perc 15 as a biomarker for the progression of emphysema, and percent change in solid tumor volume by computed tomography as a biomarker for lung cancer progression." /><link rel="canonical" href="https://clinicaltree.github.io/posts/statistical-issues-in-testing-conformance-with-the-quantitative-imaging-biomarker-alliance-qiba-pr/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/statistical-issues-in-testing-conformance-with-the-quantitative-imaging-biomarker-alliance-qiba-pr/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2016-03-31T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="Statistical Issues in Testing Conformance with the Quantitative Imaging Biomarker Alliance (QIBA) Profile Claims" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-10T03:59:08+00:00","datePublished":"2016-03-31T17:00:00+00:00","description":"A major initiative of the Quantitative Imaging Biomarker Alliance is to develop standards-based documents called “Profiles,” which describe one or more technical performance claims for a given imaging modality. The term “actor” denotes any entity (device, software, or person) whose performance must meet certain specifications for the claim to be met. The objective of this paper is to present the statistical issues in testing actors’ conformance with the specifications. In particular, we present the general rationale and interpretation of the claims, the minimum requirements for testing whether an actor achieves the performance requirements, the study designs used for testing conformity, and the statistical analysis plan. We use three examples to illustrate the process: apparent diffusion coefficient in solid tumors measured by MRI, change in Perc 15 as a biomarker for the progression of emphysema, and percent change in solid tumor volume by computed tomography as a biomarker for lung cancer progression.","headline":"Statistical Issues in Testing Conformance with the Quantitative Imaging Biomarker Alliance (QIBA) Profile Claims","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/statistical-issues-in-testing-conformance-with-the-quantitative-imaging-biomarker-alliance-qiba-pr/"},"url":"https://clinicaltree.github.io/posts/statistical-issues-in-testing-conformance-with-the-quantitative-imaging-biomarker-alliance-qiba-pr/"}</script><title>Statistical Issues in Testing Conformance with the Quantitative Imaging Biomarker Alliance (QIBA) Profile Claims | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>Statistical Issues in Testing Conformance with the Quantitative Imaging Biomarker Alliance (QIBA) Profile Claims</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>Statistical Issues in Testing Conformance with the Quantitative Imaging Biomarker Alliance (QIBA) Profile Claims</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1459443600" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Mar 31, 2016 </em> </span> <span> Updated <em class="" data-ts="1681099148" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 10, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Nancy A. Obuchowski PhD</a> </em>, <em> <a href="">Andrew Buckler MS</a> </em>, <em> <a href="">Paul Kinahan PhD</a> </em>, <em> <a href="">Heather Chen-Mayer PhD</a> </em>, <em> <a href="">Nicholas Petrick PhD</a> </em>, <em> <a href="">Daniel P. Barboriak MD</a> </em>, <em> <a href="">Jennifer Bullen MS</a> </em>, <em> <a href="">Huiman Barnhart PhD</a> </em>, <em> <a href="">Daniel C. Sullivan MD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="3285 words"> <em>18 min</em> read</span></div></div></div><div class="post-content"><p>A major initiative of the Quantitative Imaging Biomarker Alliance is to develop standards-based documents called “Profiles,” which describe one or more technical performance claims for a given imaging modality. The term “actor” denotes any entity (device, software, or person) whose performance must meet certain specifications for the claim to be met. The objective of this paper is to present the statistical issues in testing actors’ conformance with the specifications. In particular, we present the general rationale and interpretation of the claims, the minimum requirements for testing whether an actor achieves the performance requirements, the study designs used for testing conformity, and the statistical analysis plan. We use three examples to illustrate the process: apparent diffusion coefficient in solid tumors measured by MRI, change in Perc 15 as a biomarker for the progression of emphysema, and percent change in solid tumor volume by computed tomography as a biomarker for lung cancer progression.</p><h2 id="introduction"><span class="mr-2">Introduction</span><a href="#introduction" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>The Quantitative Imaging Biomarker Alliance (QIBA) initiative is to advance quantitative imaging and the use of quantitative imaging biomarkers (QIBs) both in clinical trials and in clinical practice . One effort in this initiative is to develop standards-based quantitative imaging documents called “Profiles.” These Profiles describe the (1) clinical context for the biomarker, (2) one or more technical performance claims for a given imaging modality (e.g. precision of the measurement for computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography, or ultrasound), (3) a list of actors including hardware and software that play defined roles in meeting the claims, (4) technical and performance requirements for each of those actors organized by activities they perform for achieving the claims, (5) summaries of the groundwork scientific studies that support the technical performance claims, and (6) procedures for testing conformity to the technical and performance requirements or an overarching claim. The term “actor” is used in QIBA Profiles to denote any entity (device, software, person, or site) whose performance must meet certain specifications for the claim to be met.</p><p>Through a large volunteer effort, two workshops sponsored by QIBA were conducted to develop standard statistical methods for defining technical performance metrics for QIBs . These statistical methods provide the framework for comparing technical performances of imaging procedures in the groundwork studies and for characterizing the performance in the Profile claims.</p><p>The objective of this paper is to present the statistical issues in testing conformance to the performance requirements in the QIBA Profiles. In particular, we present the general rationale and interpretation of the claims, the minimum requirements for testing whether an actor achieves the performance requirements, the study designs used for testing conformity, and the statistical analysis plan for the test. We use three examples to illustrate the process:</p><ul><li><p>1. Apparent diffusion coefficient (ADC) in solid tumors measured by MRI to gain insight into the microstructural composition of a tumor,</p><li><p>2. Change in Perc 15 (the 15th percentile of the attenuation curve as measured by CT) as a biomarker for the progression of emphysema, and</p><li><p>3. <a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p></ul><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="qibas-performance-claims"><span class="mr-2">QIBA’s Performance Claims</span><a href="#qibas-performance-claims" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="understanding-the-claim-statements"><span class="mr-2">Understanding the Claim Statements</span><a href="#understanding-the-claim-statements" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="determining-appropriate-values-to-use-in-the-claim-statements"><span class="mr-2">Determining Appropriate Values to Use in the Claim Statements</span><a href="#determining-appropriate-values-to-use-in-the-claim-statements" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>TABLE 1</p><p>Guidelines for Choosing Values for Claim Statements</p><p>Step Description 1 Choose statistical metric for performance 2 Determine patient and/or tumor characteristics that can degrade performance for the quantitative imaging biomarker 3 Identify plausible set of values for performance 4 Consider clinical requirements for performance 5 Consider the sample size requirements for actors to test their imaging procedure against the claim value 6 Choose the performance value from the plausible set of values in step 3, taking into consideration steps 4–5.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="step-1-choose-metric"><span class="mr-2">Step 1: Choose Metric</span><a href="#step-1-choose-metric" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>TABLE 2</p><p>Statistical Metrics Used in the Claim Statements</p><p>Example Rationale Statistical Metric Interpretation ADC in solid tumors Cross-sectional claim with negligible bias Within-subject (or within-tumor) standard deviation (wSD) × (95% confidence factor) The variability seen in multiple measurements on a subject when no biologic change has occurred and the same imaging procedures are used for all measurements. Change in Perc 15 for monitoring emphysema Longitudinal claim;</p><p>Same imaging procedures at two time points WRepeatability</p><p>coefficient (RC) The difference between any two measurements on a case is expected to fall between −RC and +RC for 95% of replicated measurements. It represents the minimum detectable difference, with 95% confidence. % Change in CT tumor volume Longitudinal claim;</p><p>Different imaging procedures at two time points Reproducibility coefficient (RDC) is used in the claim statement. The total deviation index with 95% coverage for change (TDI 95% ) is used for testing conformance. The RDC is a measure of precision that is used when imaging procedures differ at the two time points. It has a similar interpretation as the RC: it is the minimum detectable difference, with 95% confidence. Because it can be measured directly from clinical studies, it is used in the claim statement. When testing conformance, the bias of the imaging procedures at the two time points will likely differ and this must be accounted for. Thus, the TDI is used for conformance testing. It includes components of both precision and bias. Of the differences between the measurements and their true value, 95% is &lt;TDI 95% . The TDI cannot be measured directly; rather, an actor’s bias and precision are estimated in separate studies. See section on Trade-off between Precision and Bias</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="step-2-determine-characteristics-which-degrade-precision"><span class="mr-2">Step 2: Determine Characteristics Which Degrade Precision</span><a href="#step-2-determine-characteristics-which-degrade-precision" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="step-3-identify-plausible-set-of-values"><span class="mr-2">Step 3: Identify Plausible Set of Values</span><a href="#step-3-identify-plausible-set-of-values" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="step-4-consider-clinical-requirements"><span class="mr-2">Step 4: Consider Clinical Requirements</span><a href="#step-4-consider-clinical-requirements" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="step-5-consider-sample-size-for-conformance-test"><span class="mr-2">Step 5: Consider Sample Size for Conformance Test</span><a href="#step-5-consider-sample-size-for-conformance-test" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Ho​:theactor’sperformanceisworsethantherequirementvs.HA​:theactor’sperformanceisatleastasgoodastherequirement H</p><p>o</p><p>​</p><p>:</p><p>t</p><p>h</p><p>e</p><p>actor</p><p>’</p><p>s</p><p>performance</p><p>i</p><p>s</p><p>worse</p><p>than</p><p>t</p><p>h</p><p>e</p><p>requirement</p><p>vs</p><p>.</p><p>H</p><p>A</p><p>​</p><p>:</p><p>t</p><p>h</p><p>e</p><p>actor</p><p>’</p><p>s</p><p>performance</p><p>i</p><p>s</p><p>a</p><p>t</p><p>least</p><p>a</p><p>s</p><p>good</p><p>a</p><p>s</p><p>t</p><p>h</p><p>e</p><p>requirement</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>TABLE 3</p><p>Sample Size for Test of Precision Using Repeatability Coefficient</p><p>(θ/δ) 2 # Cases Needed 0.1 4 0.2 7 0.3 11 0.4 17 0.5 29 0.6 51 0.7 102 0.8 256</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="step-6-choose-performance-value"><span class="mr-2">Step 6: Choose Performance Value</span><a href="#step-6-choose-performance-value" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="minimum-conformance-requirements"><span class="mr-2">Minimum Conformance Requirements</span><a href="#minimum-conformance-requirements" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/StatisticalIssuesinTestingConformancewiththeQuantitativeImagingBiomarkerAllianceQIBAProfileClaims/0_1s20S1076633216000544.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/StatisticalIssuesinTestingConformancewiththeQuantitativeImagingBiomarkerAllianceQIBAProfileClaims/0_1s20S1076633216000544.jpg" alt="Figure 1, Illustration of the concepts discussed in this paper, with the Profile content identified on the left and the testing identified on the right. Proceeding diagonally down from top left hand side, Quantitative Imaging Biomarker Alliance (QIBA) Profiles identify Claims in Section 2 of the document template and Requirements for each type of Actor in Section 3 of the document. Section 3 may also articulate requirements for an ongoing Quality Assurance (QA) activity to be conducted at sites if it is judged by Profile authors that stability of the system is not assured. Proceeding from left to right are successive scopes of testing. Whereas at the highest level, the Profile Claims are tested by all Actors working together in a Field Test, Conformance Tests are performed for individual Actors according to the Requirements set for them, and if requirements for QA have been documented, these are further tested. At the bottom of the diagram are individual patient studies themselves. (Color version of figure is available online)." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><ul><li><p>1. <a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><li><p>2. <a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><li><p>3. <a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p></ul><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/StatisticalIssuesinTestingConformancewiththeQuantitativeImagingBiomarkerAllianceQIBAProfileClaims/1_1s20S1076633216000544.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/StatisticalIssuesinTestingConformancewiththeQuantitativeImagingBiomarkerAllianceQIBAProfileClaims/1_1s20S1076633216000544.jpg" alt="Figure 2, Flow chart of five testing scenarios and minimum testing requirements for each. TDI, total deviation index. (Color version of figure is available online)." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="testing-conformity"><span class="mr-2">Testing Conformity</span><a href="#testing-conformity" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="steps-in-testing-conformity"><span class="mr-2">Steps in Testing Conformity</span><a href="#steps-in-testing-conformity" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>TABLE 4</p><p>Testing Precision Using CT Volumetry for Illustration \*</p><p>Step Description 1. Make measurements on <em>N</em> cases For each case, measure the tumor volume at time point 1 (denoted Y i1 ) and at time point 2 (Y i2 ) where <em>i</em> denotes the <em>i</em> -th case ( <em>i</em> = 1, 2, … <em>N</em> ). 2. For each case, calculate mean and wSD 2 For each case, calculate the mean and within-tumor SD: Y¯¯¯i=(Yi1+Yi2)/2 Y</p><p>¯</p><p>i</p><p>=</p><p>(</p><p>Y</p><p>i</p><p>1</p><p>+</p><p>Y</p><p>i</p><p>2</p><p>)</p><p>/</p><p>2 and wSD2i=(Yi1−Yi2)2/2 w</p><p>S</p><p>D</p><p>i</p><p>2</p><p>=</p><p>(</p><p>Y</p><p>i</p><p>1</p><p>−</p><p>Y</p><p>i</p><p>2</p><p>)</p><p>2</p><p>/</p><p>2 . (Note that some authors suggest a correction to this wSD estimate or a model-based estimate to account for the small number of replicate measurements.) 3. Estimate wSD or wCV From the <em>N</em> cases, estimate within-tumor SD (wSD) or CV (wCV):</p><p>wSD=∑Ni=1wSD2i/N−−−−−−−−−−−−√ w</p><p>S</p><p>D</p><p>=</p><p>∑</p><p>i</p><p>=</p><p>1</p><p>N</p><p>w</p><p>S</p><p>D</p><p>i</p><p>2</p><p>/</p><p>N and wCV=∑Ni=1(wSD2i/Y¯¯¯2i)/N−−−−−−−−−−−−−−−−−−√ w</p><p>C</p><p>V</p><p>=</p><p>∑</p><p>i</p><p>=</p><p>1</p><p>N</p><p>(</p><p>w</p><p>S</p><p>D</p><p>i</p><p>2</p><p>/</p><p>Y</p><p>¯</p><p>i</p><p>2</p><p>)</p><p>/</p><p>N .</p><p>(Note that averaging over the <em>N</em> cases is appropriate when we can assume that the wSD is constant over the range of tumor volume values.) 4. Estimate RC or %RC \* Estimate the repeatability coefficient (RC) or %RC:</p><p>RCˆ=2.77×wSD R</p><p>C</p><p>=</p><p>2.77</p><p>×</p><p>w</p><p>S</p><p>D and %RCˆ=2.77×wCV×100 %</p><p>R</p><p>C</p><p>=</p><p>2.77</p><p>×</p><p>w</p><p>C</p><p>V</p><p>×</p><p>100 . For the CT volumetry example, %RC is used. 5. Calculate test statistic and assess compliance The null hypothesis is that the RC does not satisfy the requirement in the Profile (i.e. the RC is too large); the alternative hypothesis is that the RC does satisfy the requirement. The test statistic T is: T=N×(%RCˆ2)δ2 T</p><p>=</p><p>N</p><p>×</p><p>(</p><p>%</p><p>R</p><p>C</p><p>2</p><p>)</p><p>δ</p><p>2 , where δ δ is the performance value from the Profile claim statement (i.e. δ=40% δ</p><p>=</p><p>40</p><p>% ). Compliance with the claim is shown if T&lt;χ2α,N T</p><p>&lt;</p><p>χ</p><p>α</p><p>,</p><p>N</p><p>2 , where χ2α,N χ</p><p>α</p><p>,</p><p>N</p><p>2 is the α-th percentile of a chi square distribution † with <em>N</em> degrees of freedom (for a one-sided test with α type I error rate). 6. Construct precision profile Estimate %RC as a function of tumor size and check that all %RC≤δ %</p><p>RC</p><p>≤</p><p>δ ?.</p><p>CI, confidence interval; RC, repeatability coefficient; SD, standard deviation; wCV, within-tumor coefficient of variation; wSD, within-tumor standard deviation.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>TABLE 5</p><p>Testing Bias and Linearity using CT Volumetry for Illustration \*</p><p>Step Description 7: Make measurements from <em>N</em> cases For each case calculate the tumor volume (denoted Y i ), where <em>i</em> denotes the <em>i</em> -th case ( <em>i</em> = 1, 2, … <em>N</em> ). 8. Calculate individual bias For each case calculate the bias or % bias:</p><p>bi=(Yi−Xi) b</p><p>i</p><p>=</p><p>(</p><p>Y</p><p>i</p><p>−</p><p>X</p><p>i</p><p>) and %bi=[(Yi−Xi)/Xi]×100 %</p><p>b</p><p>i</p><p>=</p><p>[</p><p>(</p><p>Y</p><p>i</p><p>−</p><p>X</p><p>i</p><p>)</p><p>/</p><p>X</p><p>i</p><p>]</p><p>×</p><p>100 , where X i is the measurand value (i.e. true value). For CT volumetry, % <em>b</em> is used. 9. Estimate overall bias and its variance \* Over <em>N</em> cases, estimate the bias: bˆ=∑Ni=1%bi/N b</p><p>=</p><p>∑</p><p>i</p><p>=</p><p>1</p><p>N</p><p>%</p><p>b</p><p>i</p><p>/</p><p>N . The estimate of the variance of the bias (i.e. between-case variance) is Varˆb=∑Ni=1(%bi−bˆ)2/(N−1) V</p><p>a</p><p>r</p><p>b</p><p>=</p><p>∑</p><p>i</p><p>=</p><p>1</p><p>N</p><p>(</p><p>%</p><p>b</p><p>i</p><p>−</p><p>b</p><p>)</p><p>2</p><p>/</p><p>(</p><p>N</p><p>−</p><p>1</p><p>) . 10. Construct 95% CI for bˆ b</p><p>The 95% CI for the bias is bˆ±tα=0.025,(N−1)df×Varˆb−−−−√ b</p><p>±</p><p>t</p><p>α</p><p>=</p><p>0.025</p><p>,</p><p>(</p><p>N</p><p>−</p><p>1</p><p>)</p><p>d</p><p>f</p><p>×</p><p>V</p><p>a</p><p>r</p><p>b , where tα=0.025,(N−1)df t</p><p>α</p><p>=</p><p>0.025</p><p>,</p><p>(</p><p>N</p><p>−</p><p>1</p><p>)</p><p>d</p><p>f is from the Student <em>t</em> distribution † with α = 0.025 and ( <em>N</em> − 1) degrees of freedom. To test whether the actor’s bias satisfies the performance requirement in the Profile, the smallest and largest values in the 95% CI are examined. If the smallest value is greater than the minimum requirement stated in the Profile and the largest value is less than the maximum requirement stated in the Profile, then the performance requirement for the overall bias is met. 11. Bias Profile Separate the cases into strata based on covariates known to affect bias (tumor size and density). For each stratum, estimate the bias. 12. Perform OLS regression Fit an ordinary least squares (OLS) regression of the Y i s on X i s. A quadratic term is first included in the model to rule out nonlinear relationships: Y=βo+β1X+β2X2 Y</p><p>=</p><p>β</p><p>o</p><p>+</p><p>β</p><p>1</p><p>X</p><p>+</p><p>β</p><p>2</p><p>X</p><p>2 . Then a linear model should be fit: Y=βo+β1X Y</p><p>=</p><p>β</p><p>o</p><p>+</p><p>β</p><p>1</p><p>X where R-squared (R 2 ) &gt; 0.90. 13. Construct 95% CI for slope Let β1ˆ β</p><p>1</p><p>denote the estimated slope from step 12 (assuming β2=0 β</p><p>2</p><p>=</p><p>0 ). Calculate its variance as Varˆβ1={∑Ni=1(Yi−Yˆi)2/(N−2)}/∑Ni=1(Xi−X¯¯¯)2 V</p><p>a</p><p>r</p><p>β</p><p>1</p><p>=</p><p>{</p><p>∑</p><p>i</p><p>=</p><p>1</p><p>N</p><p>(</p><p>Y</p><p>i</p><p>−</p><p>Y</p><p>i</p><p>)</p><p>2</p><p>/</p><p>(</p><p>N</p><p>−</p><p>2</p><p>)</p><p>}</p><p>/</p><p>∑</p><p>i</p><p>=</p><p>1</p><p>N</p><p>(</p><p>X</p><p>i</p><p>−</p><p>X</p><p>¯</p><p>)</p><p>2 , where Yˆi Y</p><p>i is the fitted value of Y i from the regression line and X¯¯¯ X</p><p>¯ is the mean of the true values. The 95% CI is β1ˆ±tα=0.025,(N−2)dfVarˆβ1−−−−−√ β</p><p>1</p><p>±</p><p>t</p><p>α</p><p>=</p><p>0.025</p><p>,</p><p>(</p><p>N</p><p>−</p><p>2</p><p>)</p><p>d</p><p>f</p><p>V</p><p>a</p><p>r</p><p>β</p><p>1</p><p>CI, confidence interval; OLS, ordinary least squares.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="precision"><span class="mr-2">Precision</span><a href="#precision" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Ho​:θ&gt;δversusHA​:θ≤δ H</p><p>o</p><p>​</p><p>:</p><p>θ</p><blockquote></blockquote><p>δ</p><p>versus</p><p>H</p><p>A</p><p>​</p><p>:</p><p>θ</p><p>≤</p><p>δ</p><p>where θ is the actor’s precision (e.g. the actor’s RC, where larger values indicate worse precision) and δ is the precision value from the claim statement. This is a one-sided test, i.e. under the null hypothesis, the actor’s precision is considered inferior to the Profile claim. If the null hypothesis is rejected, then we conclude that the actor’s precision is at least as good as the performance in the claim statement (alternative hypothesis).</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="bias"><span class="mr-2">Bias</span><a href="#bias" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="linearity"><span class="mr-2">Linearity</span><a href="#linearity" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/StatisticalIssuesinTestingConformancewiththeQuantitativeImagingBiomarkerAllianceQIBAProfileClaims/2_1s20S1076633216000544.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/StatisticalIssuesinTestingConformancewiththeQuantitativeImagingBiomarkerAllianceQIBAProfileClaims/2_1s20S1076633216000544.jpg" alt="Figure 3, Illustration of the effect of Slope ≠ 1 on measurements of change. (Color version of figure is available online)." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="trade-off-between-precision-and-bias"><span class="mr-2">Trade-off between Precision and Bias</span><a href="#trade-off-between-precision-and-bias" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>TDI95%ˆ=Φ−1(1−1−0.952)|εˆ| T</p><p>D</p><p>I</p><p>95</p><p>%</p><p>=</p><p>Φ</p><p>−</p><p>1</p><p>(</p><p>1</p><p>−</p><p>1</p><p>−</p><p>0.95</p><p>2</p><p>)</p><p>|</p><p>ε</p><p>|</p><p>where Φ−1 Φ</p><p>−</p><p>1 is the inverse cumulative normal distribution (i.e. 1.96 for 95% coverage) and εˆ ε</p><p>is the estimate of the root mean square deviation:</p><p>MSDˆ=εˆ2=(bias)2+s2Y​, M</p><p>S</p><p>D</p><p>=</p><p>ε</p><p>2</p><p>=</p><p>(</p><p>bias</p><p>)</p><p>2</p><p>+</p><p>s</p><p>Y</p><p>2</p><p>​</p><p>,</p><p>where <em>bias</em> is an estimate of the bias of the measurements (from step 9 in Table 5 ) and s2Y s</p><p>Y</p><p>2 is an estimate of the within-subject (e.g. within-tumor) variance (from step 3 in Table 4 ).</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/StatisticalIssuesinTestingConformancewiththeQuantitativeImagingBiomarkerAllianceQIBAProfileClaims/3_1s20S1076633216000544.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/StatisticalIssuesinTestingConformancewiththeQuantitativeImagingBiomarkerAllianceQIBAProfileClaims/3_1s20S1076633216000544.jpg" alt="Figure 4, Illustration of the trade-off between Precision (expressed as the repeatability coefficient [RC]) and Bias for constant total deviation index with 95% coverage (TDI 95% ) of 40%." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="sample-size-requirements-for-testing-conformity"><span class="mr-2">Sample Size Requirements for Testing Conformity</span><a href="#sample-size-requirements-for-testing-conformity" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Ho​:θ&gt;δversusHA​:θ≤δ H</p><p>o</p><p>​</p><p>:</p><p>θ</p><blockquote></blockquote><p>δ</p><p>versus</p><p>H</p><p>A</p><p>​</p><p>:</p><p>θ</p><p>≤</p><p>δ</p><p>where θ is the actor’s precision and δ is the precision value from the claim statement. To compute sample size for a study to test this set of hypotheses, the following must be specified:</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><ul><li><p>1. <a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><li><p>2. <a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><li><p>3. <a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p></ul><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>TABLE 6</p><p>Sample Size for Evaluating Bias</p><p>Half-width of 95% Confidence Interval for Bias ±1% ±2% ±3% ±4% ±5% Var b \* = 5% 22 8 ≤5 ≤5 ≤5 Var b = 10% 42 13 7 ≤5 ≤5 Var b = 15% 61 17 9 7 ≤5 Var b = 20% 80 22 12 8 6 Var b = 25% 99 27 14 9 7</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="acknowledgement"><span class="mr-2">Acknowledgement</span><a href="#acknowledgement" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Buckler A.J., Bresolin L., Dunnick N.R., et. al.: A collaborative enterprise for multi-stakeholder participation in the advancement of quantitative imaging. Radiology 2011; 258: pp. 906-914.</p><li><p>2. Kessler L.G., Barnhart H.X., Buckler A.J., et. al.: The emerging science of quantitative imaging biomarkers: terminology and definitions for scientific studies and for regulatory submissions. Stat Methods Med Res 2015; 24: pp. 9-26.</p><li><p>3. Raunig D., McShane L.M., Pennello G., et. al.: Quantitative imaging biomarkers: a review of statistical methods for technical performance assessment. Stat Methods Med Res 2015; 24: pp. 27-67.</p><li><p>4. Obuchowski N.A., Reeves A.P., Huang E.P., et. al.: Quantitative Imaging biomarkers: a review of statistical methods for computer algorithm comparisons. Stat Methods Med Res 2015; 24: pp. 68-106.</p><li><p>5. Obuchowski N.A., Barnhart H.X., Buckler A.J., et. al.: Statistical issues in the comparison of quantitative imaging biomarker algorithms using pulmonary nodule volume as an example. Stat Methods Med Res 2015; 24: pp. 107-140.</p><li><p>6. Huang E.P., Wang X.-F., Roy Choudhury K., et. al.: Meta-analysis of the technical performance of an imaging assay: guidelines and statistical methodology. Stat Methods Med Res 2015; 24: pp. 141-174.</p><li><p>7. Available at: https://www.rsna.org/QIBA</p><li><p>8. Reeves A.P., Jirapatnakul A.C., Biancardi A.M., et. al.: The VOLCANO’09 challenge: preliminary results.Second international workshop of pulmonary image analysis.2009.pp. 353-364.</p><li><p>9. Bolch B.W.: More on unbiased estimation of the standard deviation. Am Stat 1968; 22: pp. 27.</p><li><p>10. Ashton E., Raunig D., Ng C., et. al.: Scan-rescan variability in perfusion assessment of tumors in MRI using both model and data-derived arterial input functions. J Magn Reson Imaging 2008; 28: pp. 791-796.</p><li><p>11. Petrick N., Kim H.J.G., Clunie D., et. al.: Comparison of 1D, 2D, and 3D nodule sizing methods by radiologists for spherical and complex nodules on thoracic CT phantom images. Acad Radiol 2014; 21: pp. 30-40.</p><li><p>12. Stolk J., Putter H., Bakker M.E., et. al.: Progression parameters for emphysema: a clinical investigation. Respir Med 2007; 101: pp. 1924-1930.</p><li><p>13. Dixon W.J., Massey F.J.: Introduction to statistical analysis.4th ed.1983.McGraw-HillNew York</p><li><p>14. Barnhart H.X., Barboriak D.P.: Applications of the repeatability of quantitative imaging biomarkers: a review of statistical analysis of repeat data sets. Transl Oncol 2009; 2: pp. 231-235.</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-23/'>Volume 23</a>, <a href='/categories/issue-4/'>Issue 4</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=Statistical%20Issues%20in%20Testing%20Conformance%20with%20the%20Quantitative%20Imaging%20Biomarker%20Alliance%20(QIBA)%20Profile%20Claims%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fstatistical-issues-in-testing-conformance-with-the-quantitative-imaging-biomarker-alliance-qiba-pr%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=Statistical%20Issues%20in%20Testing%20Conformance%20with%20the%20Quantitative%20Imaging%20Biomarker%20Alliance%20(QIBA)%20Profile%20Claims%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fstatistical-issues-in-testing-conformance-with-the-quantitative-imaging-biomarker-alliance-qiba-pr%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fstatistical-issues-in-testing-conformance-with-the-quantitative-imaging-biomarker-alliance-qiba-pr%2F&text=Statistical%20Issues%20in%20Testing%20Conformance%20with%20the%20Quantitative%20Imaging%20Biomarker%20Alliance%20(QIBA)%20Profile%20Claims%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/a-resident-perspective-on-adding-value-as-radiologists/"><div class="card-body"> <em class="small" data-ts="1459443600" data-df="ll" > Mar 31, 2016 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>A Resident Perspective on Adding Value as Radiologists</h3><div class="text-muted small"><p> During the annual 46th annual American Alliance of Academic Chief Residents in Radiology (A 3 CR 2 ) meeting in New Orleans, chief residents discussed the role of residents within American Colleg...</p></div></div></a></div><div class="card"> <a href="/posts/a-robust-emphysema-severity-measure-based-on-disease-subtypes/"><div class="card-body"> <em class="small" data-ts="1459443600" data-df="ll" > Mar 31, 2016 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>A Robust Emphysema Severity Measure Based on Disease Subtypes</h3><div class="text-muted small"><p> Rationale and Objectives We propose a novel single index for the quantification of emphysema severity based on an aggregation of multiple computed tomographic features evident in the lung parenchy...</p></div></div></a></div><div class="card"> <a href="/posts/bi-rads-density-classification-from-areometric-and-volumetric-automatic-breast-density-measurements/"><div class="card-body"> <em class="small" data-ts="1459443600" data-df="ll" > Mar 31, 2016 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>BI-RADS Density Classification From Areometric and Volumetric Automatic Breast Density Measurements</h3><div class="text-muted small"><p> Rationale and Objectives The aim of our study was to classify breast density using areometric and volumetric automatic measurements to best match Breast Imaging-Reporting and Data System (BI-RADS)...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/semiautomated-global-quantification-of-left-ventricular-myocardial-perfusion-at-stress-dynamic-ct/" class="btn btn-outline-primary" prompt="Older"><p>Semiautomated Global Quantification of Left Ventricular Myocardial Perfusion at Stress Dynamic CT</p></a> <a href="/posts/the-influence-of-a-vocalized-checklist-on-detection-of-multiple-abnormalities-in-chest-radiography/" class="btn btn-outline-primary" prompt="Newer"><p>The Influence of a Vocalized Checklist on Detection of Multiple Abnormalities in Chest Radiography</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
